[1]
|
Ginès, P., Krag, A., Abraldes, J.G., et al. (2021) Liver Cirrhosis. The Lancet, 398, 1359-1376.
https://doi.org/10.1016/S0140-6736(21)01374-X
|
[2]
|
徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425.
|
[3]
|
徐小元, 丁惠国, 贾继东, 等. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 中国肝脏病杂志(电子版), 2016, 8(1): 1-18.
|
[4]
|
Rösch, J., Hanafee, W.N. and Snow, H. (1969) Transjugular Portal Venography and Radiologic Portacaval Shunt: An Experimental Study. Radiology, 92, 1112-1114. https://doi.org/10.1148/92.5.1112
|
[5]
|
Buechter, M., Manka, P., Gerken, G., et al. (2018) Transjugular Intrahepatic Portosystemic Shunt in Patients with Portal Hypertension: Patency Depends on Coverage and Interventionalist’s Experi-ence. Digestive Diseases, 36, 218-227.
https://doi.org/10.1159/000486030
|
[6]
|
Garcia-Tsao, G. and Bosch, J. (2010) Management of Varices and Variceal Hemorrhage in Cirrhosis. New England Journal of Medicine, 362, 823-832. https://doi.org/10.1056/NEJMra0901512
|
[7]
|
Qi, X., Jia, J., Bai, M., et al. (2015) Transjugular Intrahepatic Por-tosystemic Shunt for Acute Variceal Bleeding. Journal of Clinical Gastroenterology, 49, 495-505. https://doi.org/10.1097/MCG.0000000000000205
|
[8]
|
De Franchis, R. (2015) Expanding Consensus in Portal Hypertension: Report of the Baveno VI Consensus Workshop: Stratifying Risk and Individualizing Care for Portal Hy-pertension. Journal of Hepatology, 63, 743-752.
https://doi.org/10.1016/j.jhep.2015.05.022
|
[9]
|
García-Pagán, J.C., Caca, K., Bureau, C., et al. (2010) Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding. New England Journal of Medicine, 362, 2370-2379. https://doi.org/10.1056/NEJMoa0910102
|
[10]
|
Lv, Y., Zuo, L., Zhu, X., et al. (2019) Identifying Optimal Candi-dates for Early TIPS among Patients with Cirrhosis and Acute Variceal Bleeding: A Multicentre Observational Study. Gut, 68, 1297-1310.
https://doi.org/10.1136/gutjnl-2018-317057
|
[11]
|
Bosch, J. and García-Pagán, J.C. (2003) Prevention of Variceal Rebleeding. The Lancet, 361, 952-954.
https://doi.org/10.1016/S0140-6736(03)12778-X
|
[12]
|
Albillos, A. and Tejedor, M. (2014) Secondary Prophylaxis for Esophageal Variceal Bleeding. Clinics in Liver Disease, 18, 359-370. https://doi.org/10.1016/j.cld.2014.01.007
|
[13]
|
Angeli, P., Bernardi, M., Villanueva, C., et al. (2018) EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis. Journal of Hepatology, 69, 406-460. https://doi.org/10.1016/j.jhep.2018.03.024
|
[14]
|
Holster, I.L., Tjwa, E.T., Moelker, A., et al. (2016) Covered Transjugular Intrahepatic Portosystemic Shunt versus Endoscopic Therapy+ β‐Blocker for Prevention of Variceal Re-bleeding. Hepatology, 63, 581-589.
https://doi.org/10.1002/hep.28318
|
[15]
|
Lv, Y., Qi, X., He, C., et al. (2018) Covered TIPS versus Endoscopic Band Ligation plus Propranolol for the Prevention of Variceal Rebleeding in Cirrhotic Patients with Portal Vein Thrombosis: A Randomised Controlled Trial. Gut, 67, 2156-2168. https://doi.org/10.1136/gutjnl-2017-314634
|
[16]
|
Gordon, F.D. (2012) Ascites. Clinics in Liver Disease, 16, 285-299. https://doi.org/10.1016/j.cld.2012.03.004
|
[17]
|
徐小元, 丁惠国, 李文刚, 等. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863.
|
[18]
|
Salerno, F., Guevara, M., Bernardi, M., et al. (2010) Refractory Ascites: Pathogenesis, Definition and Therapy of a Severe Complication in Patients with Cirrhosis. Liver International, 30, 937-947.
https://doi.org/10.1111/j.1478-3231.2010.02272.x
|
[19]
|
Bureau, C., Thabut, D., Oberti, F., et al. (2017) Transjugu-lar Intrahepatic Portosystemic Shunts with Covered Stents Increase Transplant-Free Survival of Patients with Cirrhosis and Recurrent Ascites. Gastroenterology, 152, 157-163.
https://doi.org/10.1053/j.gastro.2016.09.016
|
[20]
|
De Franchis, R., Bosch, J., Garcia-Tsao, G., et al. (2022) Baveno VII-Renewing Consensus in Portal Hypertension. Journal of Hepatology, 76, 959-974. https://doi.org/10.1016/j.jhep.2021.12.022
|
[21]
|
D’amico, G., Luca, A., Morabito, A., et al. (2005) Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis. Gastroenterology, 129, 1282-1293. https://doi.org/10.1053/j.gastro.2005.07.031
|
[22]
|
Rössle, M. and Gerbes, A.L. (2010) TIPS for the Treatment of Refractory Ascites, Hepatorenal Syndrome and Hepatic hydrothorax: A Critical Update. Gut, 59, 988-1000. https://doi.org/10.1136/gut.2009.193227
|
[23]
|
陈斌, 范文哲, 向贤宏, 等. 美国肝病研究学会(AASLD)实践指南: 经颈静脉肝内门体分流术(TIPS)在治疗门脉高压症中的作用[J]. 影像诊断与介入放射学, 2010, 19(4): 242-249.
|
[24]
|
陈辉, 吕勇, 王秋和, 等. 经颈静脉肝内门体分流术专家共识[J]. 临床肝胆病杂志, 2017, 33(7): 1218-1228.
|
[25]
|
Dhanasekaran, R., West, J.K., Gonzales, P.C., et al. (2010) Transjugular Intrahepatic Portosystemic Shunt for Symptomatic Refractory Hepatic Hydrothorax in Patients with Cirrhosis. Official Journal of the American Col-lege of Gastroenterology ACG, 105, 635-641. https://doi.org/10.1038/ajg.2009.634
|
[26]
|
梁家琦, 刘汶. 肝肾综合征的中西医结合诊治[J]. 临床肝胆病杂志, 2022, 38(9): 1974-1979.
|
[27]
|
Wong, F. (2012) Recent Advances in Our Understanding of Hepatorenal Syndrome. Nature Reviews Gastroenterology & Hepatology, 9, 382-391. https://doi.org/10.1038/nrgastro.2012.96
|
[28]
|
Angeli, P., Ginès, P., Wong, F., et al. (2015) Diagnosis and Man-agement of Acute Kidney Injury in Patients with Cirrhosis: Revised Consensus Recommendations of the International Club of Ascites. Gut, 64, 531-537.
https://doi.org/10.1136/gutjnl-2014-308874
|
[29]
|
Ginès, P., Cárdenas, A., Arroyo, V., et al. (2004) Management of Cirrhosis and Ascites. New England Journal of Medicine, 350, 1646-1654. https://doi.org/10.1056/NEJMra035021
|
[30]
|
Wong, F., Pantea, L. and Sniderman, K. (2004) Midodrine, Octreotide, Albumin, and TIPS in Selected Patients with Cirrhosis and Type 1 Hepatorenal Syndrome. Hepatology, 40, 55-64. https://doi.org/10.1002/hep.20262
|
[31]
|
Brensing, K., Textor, J., Perz, J., et al. (2000) Long Term Outcome after Transjugular Intrahepatic Portosystemic Stent-Shunt in Non-Transplant Cirrhotics with Hepatorenal Syndrome: A Phase II Study. Gut, 47, 288-295.
https://doi.org/10.1136/gut.47.2.288
|
[32]
|
Luca, A., Miraglia, R., Caruso, S., et al. (2011) Short- and Long-Term Effects of the Transjugular Intrahepatic Portosystemic Shunt on Portal Vein Thrombosis in Patients with Cirrhosis. Gut, 60, 846-852.
https://doi.org/10.1136/gut.2010.228023
|
[33]
|
曹家伟, 丁鹏绪, 段峰, 等. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版) [J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699.
|
[34]
|
Fagiuoli, S., Bruno, R., Venon, W.D., et al. (2017) Consensus Conference on TIPS Management: Techniques, Indications, Contraindications. Digestive and Liver Disease, 49, 121-137. https://doi.org/10.1016/j.dld.2016.10.011
|
[35]
|
Perarnau, J.M., Le Gouge, A., Nicolas, C., et al. (2014) Covered vs. Uncovered Stents for Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial. Journal of Hepatology, 60, 962-968.
https://doi.org/10.1016/j.jhep.2014.01.015
|
[36]
|
Yang, Z., Han, G., Wu, Q., et al. (2010) Patency and Clinical Out-comes of Transjugular Intrahepatic Portosystemic Shunt with Polytetrafluoroethylene‐Covered Stents versus Bare Stents: A Meta-Analysis. Journal of Gastroenterology and Hepatology, 25, 1718-1725. https://doi.org/10.1111/j.1440-1746.2010.06400.x
|
[37]
|
Bai, M., He, C.-Y., Qi, X.-S., et al. (2014) Shunting Branch of Portal Vein and Stent Position Predict Survival after Transjugular Intrahepatic Portosystemic Shunt. World Journal of Gastroenterology: WJG, 20, 774.
https://doi.org/10.3748/wjg.v20.i3.774
|
[38]
|
Vilstrup, H., Amodio, P., Bajaj, J., et al. (2014) Hepatic Encephalopa-thy in Chronic Liver Disease: 2014 Practice Guideline by AASLD and EASL. Hepatology, 60, 715-735. https://doi.org/10.1002/hep.27210
|
[39]
|
Rössle, M. (2013) TIPS: 25 Years Later. Journal of Hepatology, 59, 1081-1093.
https://doi.org/10.1016/j.jhep.2013.06.014
|
[40]
|
Bai, M., Qi, X., Yang, Z., et al. (2011) Predictors of Hepatic En-cephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Patients: A Systematic Review. Journal of Gastroenterology and Hepatology, 26, 943-951.
https://doi.org/10.1111/j.1440-1746.2011.06663.x
|